Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2023, Vol. 37 ›› Issue (5): 50-53.doi: 10.6040/j.issn.1673-3770.0.2022.433

• Original Article • Previous Articles     Next Articles

Diagnostic utility of folate receptor-positive circulating tumor cells in patients with laryngeal squamous cell carcinoma

ZHANG Zhuping, YE Qi, GUO Bei, LIN Ling   

  1. Department of Otolaryngology Head and Neck Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei, China
  • Published:2023-10-13

PDF (PC)

233

Abstract: Objective To determine serum levels of folate receptor-positive circulating tumor cells(FR+-CTCs)in patients with laryngeal squamous cell carcinoma(LSCC)and investigate its utility in the diagnosis of LSCC. Methods Forty-two patients with LSCC and 22 with benign laryngeal lesions admitted to the authors’ hospital were enrolled in this study. The significance of peripheral blood levels of FR+-CTCs, combined with clinical characteristics, in the diagnosis of LSCC was analyzed. Results FR+-CTC levels in patients with LSCC were higher than those in the benign group(t=7.269, P<0.001). Additionally, FR+-CTC level was associated with clinical stage, T stage, and differentiation grade(P<0.05), but not with sex, age, location, smoking, or lymph node metastasis(P>0.05). The area under the receiver operating characteristic curve was 0.857; sensitivity was 76.2% and specificity was 95.5% for the detection of LSCC with 9.0 FU/3 mL as the cut-off value. Conclusion Peripheral blood levels of FR+-CTCs in patients with LSCC were increased and was associated with clinical stage and differentiation grade. The determination of FR+-CTC levels is anticipated to be applied in the clinical diagnosis of LSCC.

Key words: Laryngeal cancer, Folate receptor, Circulating tumor cell, Serum, Biomarkers

CLC Number: 

  • R739.6
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: a cancer journal for clinicians, 2018, 68(6): 394-424. doi: 10.3410/f.734004835.793587632
[2] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016[J]. CA A Cancer J Clin, 2016, 66(1): 7-30. doi:10.3322/caac.21332
[3] Tinhofer I, Staudte S. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook[J]. Expert Rev Mol Diagn, 2018, 18(10): 897-906. doi:10.1080/14737159.2018.1522251
[4] He W, Kularatne SA, Kalli KR, et al. Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands[J]. Int J Cancer, 2008, 123(8): 1968-1973. doi:10.1002/ijc.23717
[5] 汪莹, 申复进, 郑红云, 等. 叶酸受体阳性循环肿瘤细胞在卵巢癌辅助诊断和疗效监测中的应用价值[J]. 实用临床医药杂志, 2022, 26(13): 79-83, 92. doi:10.7619/jcmp.20220206 WANG Ying, SHEN Fujin, ZHENG Hongyun, et al. Application value of folate receptor-positive circulating tumor cells in auxiliary diagnosis and therapeutic effect monitoring of ovarian cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(13): 79-83, 92. doi:10.7619/jcmp.20220206
[6] Yan S, Guo WY, Liu YL, et al. The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study[J]. Int J Clin Oncol, 2022, 27(3): 538-544. doi:10.1007/s10147-021-02097-2
[7] Li Z, Xu K, Xu LK, et al. Predictive value of folate receptor-positive circulating tumor cells for the preoperative diagnosis of lymph node metastasis in patients with lung adenocarcinoma[J]. Small Methods, 2021, 5(6): e2100152. doi:10.1002/smtd.202100152
[8] Yu Y, Chen ZL, Dong JS, et al. Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer[J]. Transl Oncol, 2013, 6(6): 697-702. doi:10.1593/tlo.13535
[9] Kong LY, Birkeland AC. Liquid biopsies in head and neck cancer: current state and future challenges[J]. Cancers(Basel), 2021, 13(8): 1874. doi:10.3390/cancers13081874
[10] 刘坤, 张欣欣. 循环肿瘤细胞在头颈部鳞癌中的富集及检测[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 18-24. doi:10.6040/j.issn.1673-3770.1.2019.039 LIU Kun, ZHANG Xinxin. Progress in clinical research on circulating tumor cells in squamous cell carcinoma of the head and neck[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 18-24. doi:10.6040/j.issn.1673-3770.1.2019.039
[11] 李倩, 郑琪, 马婕群, 等. 叶酸受体阳性循环肿瘤细胞检测的临床研究进展[J]. 标记免疫分析与临床, 2020, 27(2): 356-360. doi:10.11748/bjmy.issn.1006-1703.2020.02.036 LI Qian, ZHENG Qi, MA Jiequn, et al. The progress of clinical research on folate receptor-positive circulating tumor cells analysis[J]. Labeled Immunoassays and Clinical Medicine, 2020, 27(2): 356-360. doi:10.11748/bjmy.issn.1006-1703.2020.02.036
[12] Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions[J]. J Clin Invest, 2009, 119(6): 1429-1437. doi:10.1172/JCI36183
[13] Li Z, Xu K, Xu LK, et al. Predictive value of folate receptor-positive circulating tumor cells for the preoperative diagnosis of lymph node metastasis in patients with lung adenocarcinoma[J]. Small Methods, 2021, 5(6): e2100152. doi:10.1002/smtd.202100152
[14] Wu Q, Zheng HY, Gu J, et al. Detection of folate receptor-positive circulating tumor cells as a biomarker for diagnosis, prognostication, and therapeutic monitoring in breast cancer[J]. J Clin Lab Anal, 2022, 36(1): e24180. doi:10.1002/jcla.24180
[15] Lian SY, Yang LJ, Feng Q, et al. Folate-receptor positive circulating tumor cell is a potential diagnostic marker of prostate cancer[J]. Front Oncol, 2021, 11: 708214. doi:10.3389/fonc.2021.708214
[16] Yan S, Guo WY, Liu YL, et al. The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study[J]. Int J Clin Oncol, 2022, 27(3): 538-544. doi:10.1007/s10147-021-02097-2
[17] Wu XL, Tu Q, Faure G, et al. Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis[J]. Sci Rep, 2016, 6: 20210. doi:10.1038/srep20210
[18] Rizzo MI, Ralli M, Nicolazzo C, et al. Detection of circulating tumor cells in patients with laryngeal cancer using ScreenCell: comparative pre- and post-operative analysis and association with prognosis[J]. Oncol Lett, 2020, 19(6): 4183-4188. doi:10.3892/ol.2020.11528
[19] 陈燕. 叶酸受体在鼻咽癌、喉癌中的表达及临床意义[D]. 重庆: 重庆医科大学, 2007
[1] XIAO Junhua, PAN Qingchun, JIN Shu. Trend and projection of larynx cancer mortality caused by occupational exposure to sulfuric acid [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 55-61.
[2] SUN Qingzhu, SHEN Jian, CHEN Xing, WU Yanbing, ZENG Lun. The role of metabolic indicators in predicting ranibizumab efficacy in diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 74-81.
[3] XIE Feng, XU Zhenju, WU Ce, LIU Jie, ZANG Chuanshan, ZHANG Longxiao, HAN Min. Clinicopathologic and survival analysis of laryngeal neuroendocrine neoplasm in 26 cases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 79-86.
[4] ZHOU Heqing, SHEN Qi. Research progress on biomarkers of traditional Chinese medicine in the treatment of allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 168-176.
[5] QU Xiangyu, ZHU Han, LIU Zhonglu, MU Yakui, GUO Wentao, ZHANG Hua. Application of epiglottic tongue flap in supraglottic defect repair of laryngeal cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 77-84.
[6] ZHANG Shan, CHEN Qiu, ZHOU Fangwei, MA Yifei. Research progress of biomarkers in laryngopharyngeal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 46-54.
[7] WANG Jingsong, YU Can, ZHANG Xi, DENG Qicheng, XIE Zhuoliang, ZHAO Rui, WEN Bei, LIU Hai. Expression and clinical significance of KRT4 in laryngeal carcinoma and adjacent normal mucosal tissues [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 12-17.
[8] YANG Min, ZHU Xiaoyan, WANG Xu. Progress in metabolomics research in sensorineural hearing loss [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 113-121.
[9] WANG Lu, ZHANG Yunyun, GUO Hua, CUI Xiaochuan. Application value of lipid metabolism markers for the early screening of Alzheimer's disease in obstructive sleep apnea patients [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 68-74.
[10] HAO Hong, CHEN Gang, WANG Lin’e. Key candidate genes associated with the molecular mechanisms of adenoid cystic carcinoma identified by bioinformatics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 99-106.
[11] ZHANG Xi, DENG Qicheng, ZHANG Zhen, CHEN Yao, WANG Jingsong, ZHAO Rui, LIU Hai. Effect of nutritional support on postoperative pharyngeal fistula after laryngeal cancer surgery: a Meta-analysis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(3): 51-59.
[12] XU Chong, WANG Xiaoting, YI Hongliang. Single-cell sequencing analysis of laryngeal cancer and its microenvironmental metabolism-related target genes [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(2): 33-38.
[13] HUANG Hengfeng, MA Kunpeng, YANG Di, ZHANG Lijun, ZHANG Shenglin. Expression and clinical significance of miR-181b-5P and EPB41L3 protein in laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 41-46.
[14] WANG MeiOverview,LI ZhihaiGuidance. Laryngeal cancer stem cells: potential therapeutic targets for overcoming multidrug resistance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 120-128.
[15] WANG Xiaoting, CHEN Zhengnong, YI Hongliang. Transcriptomic analysis of glutamine deprivation on laryngeal carcinoma cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 26-31.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd